<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://vigi-eye.com/analysis/2026-11-20-view-safety-judgment-belongs-apart-from-the-product-line-and-cber-just-said-so</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>Safety judgment belongs apart from the product line, and CBER just said so</news:title></news:news></url><url><loc>https://vigi-eye.com/analysis/2026-11-20-view-definitions-decide-pathways-uk-gene-therapy-rewrite-means-check-your-category-no</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>Definitions decide pathways: UK gene therapy rewrite means check your category now</news:title></news:news></url><url><loc>https://vigi-eye.com/analysis/2026-11-20-ema-s-cmv-immunoglobulin-psusa-ends-in-maintenance-what-a-quiet-outcome-tells-pv</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>EMA&#x27;s CMV immunoglobulin PSUSA ends in maintenance: what a quiet outcome tells PV teams</news:title></news:news></url><url><loc>https://vigi-eye.com/analysis/2026-11-20-clearmind-s-hong-kong-ptsd-patent-application-is-published-not-granted</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>Clearmind&#x27;s Hong Kong PTSD patent application is published, not granted</news:title></news:news></url><url><loc>https://vigi-eye.com/analysis/2026-11-20-cms-reassigns-gastric-alimetry-code-0868t-to-apc-5724-at-1-048-77-for-2027</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>CMS reassigns Gastric Alimetry code 0868T to APC 5724 at $1,048.77 for 2027</news:title></news:news></url><url><loc>https://vigi-eye.com/analysis/2026-11-20-mhra-closes-one-idap-authorisation-as-the-pilot-stays-shut-to-new-applicants</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>MHRA closes one IDAP authorisation as the pilot stays shut to new applicants</news:title></news:news></url><url><loc>https://vigi-eye.com/analysis/2026-11-20-fda-s-510-k-transfer-q-a-what-holders-and-buyers-should-check-before-a-deal-clos</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>FDA&#x27;s 510(k) transfer Q&amp;A: what holders and buyers should check before a deal closes</news:title></news:news></url><url><loc>https://vigi-eye.com/analysis/2026-11-20-ema-keeps-famciclovir-authorisations-unchanged-after-psusa-what-maintenance-mean</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>EMA keeps famciclovir authorisations unchanged after PSUSA; what &#x27;maintenance&#x27; means for PV teams</news:title></news:news></url><url><loc>https://vigi-eye.com/analysis/2026-11-19-tablo-power-cord-overheating-alert-shows-how-a-simple-instruction-change-becomes</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Tablo power cord overheating alert shows how a simple instruction change becomes a PV control</news:title></news:news></url><url><loc>https://vigi-eye.com/analysis/2026-11-19-lantern-pharma-s-first-tnbc-site-and-taiwan-start-meet-a-ceo-exit-and-a-4-0m-rai</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Lantern Pharma&#x27;s first TNBC site and Taiwan start meet a CEO exit and a $4.0M raise</news:title></news:news></url><url><loc>https://vigi-eye.com/analysis/2026-11-19-eea-decision-191-2026-extends-six-eu-feed-additive-acts-to-eea-efta-markets-minu</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>EEA Decision 191/2026 extends six EU feed additive acts to EEA EFTA markets, minus Liechtenstein</news:title></news:news></url><url><loc>https://vigi-eye.com/analysis/2026-11-19-prescriber-fraud-plea-and-a-week-of-enforcement-signals-what-qa-and-compliance-s</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Prescriber fraud plea and a week of enforcement signals: what QA and compliance should take from it</news:title></news:news></url><url><loc>https://vigi-eye.com/analysis/2026-11-19-fda-clears-infilbray-first-therapy-for-neurological-symptoms-of-type-3-gaucher-d</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>FDA clears Infilbray, first therapy for neurological symptoms of Type 3 Gaucher disease</news:title></news:news></url><url><loc>https://vigi-eye.com/analysis/2026-11-19-ema-s-new-eurd-list-what-pv-teams-should-check-before-the-next-psur-cycle</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>EMA&#x27;s new EURD list: what PV teams should check before the next PSUR cycle</news:title></news:news></url><url><loc>https://vigi-eye.com/analysis/2026-11-18-view-your-fda-approval-package-is-now-a-global-filing-asset-plan-it-like-one</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>Your FDA approval package is now a global filing asset. Plan it like one</news:title></news:news></url><url><loc>https://vigi-eye.com/analysis/2026-11-18-fda-s-lembaz-approval-sets-a-survival-benchmark-in-infantile-onset-niemann-pick</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>FDA&#x27;s Lembaz approval sets a survival benchmark in infantile-onset Niemann-Pick type C</news:title></news:news></url><url><loc>https://vigi-eye.com/analysis/2026-11-18-medicare-aco-savings-data-what-a-pv-team-can-and-cannot-take-from-cms-s-2025-res</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>Medicare ACO savings data: what a PV team can and cannot take from CMS&#x27;s 2025 results</news:title></news:news></url><url><loc>https://vigi-eye.com/analysis/2026-11-18-cms-releases-2027-medicare-cost-sharing-parameters-what-pricing-teams-should-che</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>CMS releases 2027 Medicare cost-sharing parameters: what pricing teams should check first</news:title></news:news></url><url><loc>https://vigi-eye.com/analysis/2026-11-18-uk-and-german-device-safety-notices-what-qa-can-and-can-t-learn-from-the-public</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>UK and German device safety notices: what QA can and can&#x27;t learn from the public lists</news:title></news:news></url><url><loc>https://vigi-eye.com/analysis/2026-11-18-fda-s-global-reliance-disclosure-program-what-minimally-redacted-approval-packag</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>FDA&#x27;s Global Reliance Disclosure Program: what minimally redacted approval packages mean for filings</news:title></news:news></url><url><loc>https://vigi-eye.com/analysis/2026-11-18-class-i-on-presource-kits-shows-how-an-infusion-set-recall-travels-into-convenie</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>Class I on Presource kits shows how an infusion-set recall travels into convenience packs</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/1d577b561292d532</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>FDA early alert: Heraeus Medevio recalls vascular guidewires over hydrophilic coating clumping risk</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/5ea3ecb93303009585bb</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>Brainstorm Cell proposes governance reforms to settle NurOwn derivative suits, with $725,000 in fees</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/11b9e42cb41ddb1c7bcb</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>PMV Pharma reports 48% response rate for rezatapopt in platinum-resistant ovarian cancer</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/n/37f7f796fbe49f55120c</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>Terumo Aortic recalls all in-date Relay Pro and Treo stent-graft systems over endotoxin risk</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/355da9bfc197ee0c486a</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>J&amp;J&#x27;s Tremfya beats placebo in Phase 4 STAR axial psoriatic arthritis study at Week 24</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/bebafcdb2a5c771aeeb1</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>FDA extends review of Belite Bio&#x27;s tinlarebant for Stargardt disease to May 2027</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/n/a75b8b2f888247ffbe72</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>EMA publishes PSUSA outcome for ibuprofen medicines, concluding with a variation</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/n/d5b2f7f95407f9c5eb84</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>EMA publishes PSUSA outcome for nationally authorised split-virion inactivated influenza vaccines, recommending a variation</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/2e562460250a8a4c13e0</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>Immutep reports 81% 12-month disease-free survival in neoadjuvant soft tissue sarcoma trial</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/f50cbe43380cde3c</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>CMS proposes Medicare Advantage rule to ease market entry and widen beneficiary choice</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/71a6d672a9361e91</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>CMS issues proposed rule on 2028 Medicare Advantage and Part D changes</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/618e59cc6b252af2</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>FDA warns Florida clinical investigator over consent failings in INSTI HIV self-test study</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/2510a86d6aaf18c6</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>FDA says clinical investigator&#x27;s CAPA response falls short after CBER warning letter</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/4d7d9e915ed16674</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>BfArM publishes GE Healthcare urgent field safety notice for Centricity PACS and Enterprise Archive</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/83a06b86930d7bc0</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>Breckenridge recalls one lot of propranolol ER 60 mg capsules over possible metal contamination</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/a8f3972772916921</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>HHS awards $47 million to 15 organisations under MAHA ELEVATE for Medicare chronic disease prevention</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/5bab8c1d5298320f</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>SÚKL publishes draft Czech reimbursement list effective 20 November 2026</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/bd53d0c058865bcd</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>SÚKL launches expanded ASTERx system for pricing and reimbursement proceedings, retires Verso</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/3da8019822236da9</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>New Jersey health centre owner jailed for 180 days over billing fraud and unlicensed practice</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/70be1649a8504d08</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>Richmond couple sentenced over Medicaid mental health billing scheme worth nearly $1m</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/069e9213dba110d1</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>InnovAge settles Colorado Medicaid false claims allegations over senior care services</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/370a490b51633413</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>Former Las Vegas physician sentenced to prison over Medicaid fraud and identity theft</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/585c9ca49d8c9dd0</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>Michigan Home Health Agency Owner Gets Four Years in Prison for $1.6m Medicare Fraud</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/15a49e8bf6993889</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>South Carolina arrests 19-year-old provider over Medicaid billing for services never delivered</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/dcaca1482011952e</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>AIFA publishes outcomes of November Scientific and Economic Committee meeting</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/578b4f9ed55bf503</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>Bayer to permanently withdraw Verquvo 2.5 mg tablets from Danish market</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/c22cfd76749ed70b</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>ROSSMANN recalls selected PREVENTIVO condom batches in Czechia over quality fears</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/aadbd00dace4a79d</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>AEMPS warns of falsified CE certificate for Nanjing Bestview Laser therapeutic laser systems</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/9c96b567cd9329d9</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>Denmark flags upcoming Therios 750 mg supply gap running to April 2027</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/n/4173054278666ff37265</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20</news:publication_date><news:title>FDA publishes new and revised draft product-specific guidances on bioequivalence for generics</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/b5f7f45e47fd6583</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Dutch inspectorate posts Biotronik field safety notice on ICD and CRT-D lithium plating</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/bbefe25565ceb141</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Nova Biomedical starts field safety action on StatStrip ketone test strips over QC failures</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/29e67e6b934afc6e</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>BfArM lists ArcRoyal field safety notice for procedure trays containing BD Connecta Stopcock</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/0964142a800ba79d25fd</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Scienture Q3 revenue reaches $1.25M as REZENOPY naloxone nasal spray launches</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/824e76475138556c5cf7</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>FDA allows Alpha Tau to double REGAIN glioblastoma trial to 20 patients</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/n/ba273deb991a73d345cf</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Getinge recalls CARDIOSAVE balloon pumps in Canada over reversed-polarity capacitors</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/n/6f9f26daa8122e8dd2a3</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Health Canada posts Type II recall of Philips Bridge Prep Kit over guidewire resistance</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/n/47a863eb899b8023872f</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Olympus updates reprocessing instructions for GF-UC140P-AL5 endoscopic ultrasound gastrovideoscopes in Canada</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/n/44cd1c5a6777bf77b155</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>EMA publishes PSUSA outcome for famciclovir with &#x27;maintenance&#x27; regulatory result</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/n/7f9eeb65dbe2fe754b82</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>EMA publishes PSUSA outcome for cytomegalovirus immunoglobulin: marketing authorisations to be maintained</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/n/cd068e3ee34cb2b4586b</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Health Canada flags Type I recall of Heraeus VascuPuncture PICC guidewires over coating particle risk</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/n/1ecce63b6c1d85ceecd1</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>ICU Medical recalls Portex endotracheal tubes in Canada over plasticizer variability in resin</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/cbadc1463a213f374890</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Medicus Pharma regains Nasdaq equity compliance after equity raise and debt-for-preferred swap</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/ecde4420cd693d1b1538</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Clearmind Medicine&#x27;s psychedelic-derived PTSD compound patent application published in Hong Kong</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/dfa1d9ebd240264a0f9b</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Pyxis Oncology reports 39% confirmed response rate for micvotabart pelidotin in head and neck cancer</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/9cc67db0963bde4a2905</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Adagene doses first patient in Phase 1 trial of double-masked HER2×CD3 engager ADG138</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/55c737af2e7fcd93e6b5</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Kazia files FY2026 20-F, reporting A$61.2M cash and early paxalisib breast cancer data</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/e35f050e41b99af5e626</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Psyence Biomedical reports $1.94M half-year loss as equity line lifts cash to $21.1M</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/d177bcbaf6498336fa82</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Psyence Biomedical adds ibogaine for opioid use disorder via new Texas subsidiary</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/2920f218a5aaa45eea53</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Allarity secures US patent on twice-daily stenoparib dosing, with protection expected into 2045</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/831b00b797ff96989c68</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Evaxion refocuses on cancer vaccines as EVX-04 heads toward phase 1 filing</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/ad306e0fe3d66278a8b1</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>CytoSorbents reaches operating cash flow breakeven in Q3 as operating loss narrows 59%</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/ae2cdd8628925174843a</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>China approves HUTCHMED&#x27;s Syk inhibitor SYVIK for chronic ITP and warm autoimmune haemolytic anaemia</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/c5a5eefb15f83f706f27</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Remix&#x27;s oral MYB degrader REM-422 shows responses in 4 of 7 biomarker-positive ACC patients</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/ef9bf71c0c096ecb10c3</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Emmaus Q3 revenue falls to $1.9M after Endari licence; going-concern doubt flagged</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/e68a63819586c74d6356</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Scancell&#x27;s melanoma DNA vaccine iSCIB1+ gets FDA RMAT designation ahead of Phase 3</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/0c3109196fe75d05</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>BD Connecta stopcock lots flagged over possible tubing separation from male luer</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/8df325a5e99bb0ed</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Arthrex NanoNeedle Scope may lack programming, causing imaging console recognition failures, Dutch inspectorate notes</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/ac7d50a8a70880cf</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Dutch inspectorate publishes PharmaPartners notice after hosting failure lost Medicom and Pharmacom records</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/d7f99b065a533cc1</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>IGJ lifts restrictions on Jiaxing Tianhe BAL flush syringes made from 2026 onwards</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/bb79ac18e89285ef</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>PharmaPartners warns Pharmacom pharmacy software may show monitoring signal against wrong medicine</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/6d2e35eeafc5fd63</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>AIFA: Italy&#x27;s public pharmaceutical spending hits €13.42bn in first half of 2026</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/e88a0fac5b068603</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>AIFA: Italian public pharmaceutical spending hits €13.42bn in first half of 2026</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/c2c2d93ed57a6a92</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Infarmed orders recall of Entecavir Viatris batches over active substance contamination concerns</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/24688d740ac1b695</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>BfArM lists urgent field safety notice for Thermo Fisher&#x27;s YEASTONE BROTH diagnostic product</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/ad1bbc02a71fecb1</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>BfArM publishes Philips urgent field safety notice for Dual IBP Adapter</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/6f5938fa9ffac6ef</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>FDA publishes Q&amp;A guidance on transferring a 510(k) clearance between holders</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/32eff23348f3e0c8</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>FDA creates CBER Safety Council to oversee postmarket safety of biologics</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/6a68f4e2d839705f</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Infarmed orders recall of Entecavir Viatris batches over active substance manufacturing concerns</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/265d8718052a5119</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>ANSM sets new accreditation procedures for external quality control bodies, replacing 2019 order</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/9967c116982b6813</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>React Health recalls 7,533 Luna G3 BPAP devices over incorrect pressure data</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/0a6f915a247a20c3</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>FDA early alert: B. Braun updates Caresite Micro valve instructions over sticking piston</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/1237d04d7f681710</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Slovak regulator updates QRD Annex V after moving adverse reaction reporting form on its website</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/bbb94a88d1cddff4</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Gabapentin Orion 600 mg supply problem in Denmark expected to run into early 2027</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/8184f821b5406fda</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Michigan pharmacy owner gets 82 months for $5.6m fraud and oxycodone distribution</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/4861babccb1b3046</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Slovenia asks wholesalers to import lidocaine chloride gel amid supply disruption</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/1cf64dd1412c4553</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>AIFA activates web monitoring registry for ZIIHERA in HER2-positive biliary tract cancer</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/8be4385db78b921c</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>AIFA adds YESAFILI aflibercept to simplified anti-VEGF monitoring form for four eye indications</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/ae4c4a92a443bc48</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>SÚKL publishes Czech national hemovigilance annual report for 2025</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/eaf1923aeaa45345</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>ANSM lifts pharmacist blister checks for Arrow lenalidomide but keeps handling precautions</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/602b0ed938c465ac</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>Portugal&#x27;s CNFT updates antibiotic guidance for hospitals and primary care, stressing stewardship links</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/6f7a890f23faa13c</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>AEMPS updates contraceptive advice for women taking tirzepatide with oral contraceptives</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/8878dbfc8579212c</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>UK confirms plan to widen gene therapy definition to cover synthetic and genome-editing products</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/b92872adadc682a8</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>MHRA to legislate on revised gene therapy definition after strong consultation support</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/a0499d6290a40af8</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>EEA Joint Committee amends Annex I on veterinary and phytosanitary matters</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/18980445e4c71789</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>EEA Joint Committee amends Annex I on veterinary and phytosanitary matters in Decision 190/2026</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/2a721e4af81e8320</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>EEA Joint Committee amends veterinary, phytosanitary and technical regulation annexes in Decision No 194/2026</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/7684a6aaf9abf708</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>EEA Joint Committee amends Annex I on veterinary and phytosanitary matters in Decision 191/2026</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/f7ade181bc7b7354</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>EEA Joint Committee extends three EU feed additive rules to Iceland and Norway</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/233edaf1882b35f9</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>EEA Joint Committee adds six EU feed additive acts to Annex I of EEA Agreement</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/n/5f88842eccab2d002544</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19</news:publication_date><news:title>MHRA updates IDAP page as one Unmet Clinical Need Authorisation is closed</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/b86e4779bca9f9b7</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>FDA early alert: Tablo power cord connections may overheat, Outset Medical updates instructions</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/a2f3aa30bcd00db8</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>BfArM publishes urgent field safety notice for Bentley InnoMed&#x27;s BeFlow Iliac Covered Stent System</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/n/32cdc83302adad7f79e1</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>Health Canada lists Class II recall of Stryker&#x27;s Blueprint shoulder-planning software over two bugs</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/n/b900a624e3076f45636c</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>Teleflex recalls PICC kits and spring-wire guides over coating detachment risk, Health Canada reports</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/n/74bd54bab7de0fe71713</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>Health Canada flags Beckman Coulter DxC 500i software fault that may distort chemistry results</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/n/4e319938ba4a21570f4e</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>Health Canada: Raz Design recalls shower commode chairs over seats that can break</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/af2c9505abc693eefd93</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>CMS moves Alimetry&#x27;s Gastric Alimetry test to higher Medicare outpatient payment tier for 2027</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/ffc55cda3c41e622ce7d</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>Prenetics widens H2 EBITDA loss guidance to $30-35M as IM8 spending rises</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/7d6f7a562fb982938949</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>Summit starts Phase III HARMONi-10 of ivonescimab against durvalumab in Stage III NSCLC</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/befca81e4b86e05ab8c1</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>Quantum-Si detects all 20 amino acids at single-molecule level on Proteus platform</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/18ca2a6aa95bc4e95091</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>NeOnc deck reports Phase 2a intranasal NEO100 results in recurrent IDH1-mutant glioma</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/27671f4a22ae3d7d59ee</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>NeOnc to meet FDA in January 2027 on NEO100 accelerated approval path</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/61108086bf67f9b210e9</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>Lantern Pharma opens first TNBC trial site, starts HARMONIC Part 2 in Taiwan; CEO resigns</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/aa103861558c86af26d7</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>newcleo reports Q3 revenue of about €10M and €233.4M cash as PRECURSOR e-core completed</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/659d7e72ea0b3db3093e</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>Optimi Health seeks to make psilocybin depression study randomised Phase 2b; MDMA Phase 3 planned</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/c/72541949943ca65c87ca</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>Can-Fite completes dosing in interim cohort of Phase III piclidenoson psoriasis trial</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/n/979842eafc32f7134ad5</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>EMA publishes list of Union reference dates and PSUR submission frequencies</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/9edf275bbd603bb4</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>FDA approves Infilbray, first treatment for neurological symptoms of Type 3 Gaucher disease</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/994257e029383655</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>BfArM lists Siemens field safety notice for Dimension Urine Barbiturate Screen assay</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/18fa57f1289d3e63</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>BfArM publishes Medtronic MiniMed urgent field safety notice for MiniMed Go app</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/11d40ae739432f20</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>BfArM posts Merit Medical field safety notice for Philips BridgeT Balloon Prep Kit</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/2efbe70934c21a68</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>BfArM posts Urgent Field Safety Notice for Biomet UK&#x27;s Avantage Cup Gripper</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/d89e90d6d31312e6</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>BfArM publishes InterSystems field safety notice for TrakCare France software</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/5eb843f3ce8c9fac</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>INFARMED lifts suspension of Limeciclina Atral 408 mg capsules after bioequivalence shown</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/1aba554d584f688c</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>ANSM orders Unither&#x27;s Coutances site to fix aseptic and deviation failings within set deadlines</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/c4292c1a9ea49aef</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>ANSM amends French generic groups directory in decision dated 12 November 2026</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/785a65c35b71e5c6</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>Missouri doctor and spouse plead guilty to illegal prescribing and healthcare fraud conspiracies</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/488c5c3cf8a89bcc</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>InnovAge to pay $36m to settle False Claims Act allegations over PACE care failures</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/150df41390e40d20</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>Mississippi businessman jailed for 10 years over $19M Medicare DME fraud</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/49e7108d92d5fd4d</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>Luxembourg launches national campaign on appropriate antibiotic use for European Antibiotic Awareness Day</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/a1f70801876b2793</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>ANSM bans direct furosemide sales to pharmacies and allows compounded capsules amid shortage</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/03b0f8717297aff2</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>Denmark flags Aimovig 140 mg supply problems linked to manufacturing issues</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/613600e0391413ac</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>Denmark flags supply problems with Baxter&#x27;s Sendoxan 50 mg cyclophosphamide tablets until early December</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/8511de07b6a436c6</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>ANSM bans direct lab sales of furosemide to pharmacies as shortage seen lasting into 2027</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/dc8571db1dc3a215</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>Commission publishes minutes of SCHEER working group meeting on brain stimulators</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/3b6077e8e28c953c</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>EU Health Security Committee urges stronger action on carbapenem-resistant bacteria as infections rise</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/42fdfccad122cc5b</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>AIFA starts rolling review of daraxonrasib after positive CHMP opinion in pancreatic cancer</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/48b1ee13611dd77e</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>AIFA reminds sponsors how to pay Annual Safety Report evaluation fee</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/2816e5e66a910281</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>Portugal&#x27;s antibiotic use stays below EU average, but broad-spectrum prescribing remains a concern</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/fdd22cb435433823</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>Paul-Ehrlich-Institut Highlights Vaccines and Antibodies in Fight Against Antimicrobial Resistance</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/bee6e069f5bda240</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>MHRA develops AdvanceGxP service to bring GxP advice into early innovation</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/86ba208bca109705</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>MHRA announces AdvanceGxP service for earlier support on advanced manufacturing technologies</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/23144792c61a8e88</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>MHRA updates London AI regulatory sandbox call with next-stage application details</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/4c022c8dd289c926</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>Slovenia asks wholesalers to import estradiol 50 microgram patches amid supply disruption</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/627171d8281b8379</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>SÚKL says no Comirnaty batch inspected or vaccine withdrawn after 2020–2026 pharmacovigilance signals</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/u/2f78271f1980fd42</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>SÚKL explains why Czech pharmacies may split repeat-prescription dispensing across days</news:title></news:news></url><url><loc>https://vigi-eye.com/news/item/n/16882a5c9db976095099</loc><news:news><news:publication><news:name>VigiEye</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18</news:publication_date><news:title>MHRA updates London Region I sandbox call with next-stage application details</news:title></news:news></url></urlset>